About this episode

Dr. Haseeb Mehmood Qadri interviews Prof. Dr. Ghazaleh Tabatabai about their research on biomarker-guided therapies in neuro-oncology.

Podcast Host and Interviewee: Dr. Haseeb Mehmood Qadri interviews Prof. Dr. Ghazaleh Tabatabai Dr. Haseeb Mehmood Qadri interviews Prof. Dr. Ghazaleh Tabatabai from the Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Germany on their manuscript, entitled Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort

More episodes of Neuro-Oncology: The Podcast

• Author Interview: Prospective biopsy-controlled validation of an AI model for predicting glioblastoma infiltration: Results from the SupraGlio trial · June 1, 2026 · 29 min
• Neuro-Oncology Nugget: GT-20 Phase 1 Trial — Personalized Neoantigen DNA Vaccine for MGMT Unmethylated Glioblastoma · May 29, 2026 · 3 min
• Neuro-Oncology Narrative · May 18, 2026 · 34 min
• Hot Topics: Wellness in Neuro-oncology · May 15, 2026 · 25 min
• Neuro-Oncology Nugget: Phase 1/2 BT008NA Trial — Focused Ultrasound + Temozolomide for High-Grade Glioma · May 11, 2026 · 4 min
• SNObound: Career description and advice from Dr. Ryan Cecchi in Neuropathology · May 8, 2026 · 20 min

Explore listener stats, chart rankings, contacts and more on the Neuro-Oncology: The Podcast podcast page.